Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
Fusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure. This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor abla...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/390912 |
id |
doaj-aed6aafcd0124545b6d4b82cf46de959 |
---|---|
record_format |
Article |
spelling |
doaj-aed6aafcd0124545b6d4b82cf46de9592020-11-24T23:06:35ZengHindawi LimitedCase Reports in Urology2090-696X2090-69782012-01-01201210.1155/2012/390912390912Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell CarcinomaHayet Amalou0Bradford J. Wood1Center for Interventional Oncology, NIH Clinical Center, National Institutes of Health, MSC 1182, Bethesda, MD 20892, USACenter for Interventional Oncology, NIH Clinical Center, National Institutes of Health, MSC 1182, Bethesda, MD 20892, USAFusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure. This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor ablation, in whom there is a desire to minimize or avoid nephrotoxic iodinated contrast exposure. EM tracking software merges and fuses different imaging modalities such as MRI, CT, and ultrasound and can also display the position of needles in real time in relation to preprocedure imaging, which may better define tumor targets than available intraoperative imaging. EM tracking was successfully used to ablate a poorly visualized renal tumor, through the combined use of CT, gadolinium-enhanced MR, and contrast-enhanced US imaging to localize the tumor.http://dx.doi.org/10.1155/2012/390912 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hayet Amalou Bradford J. Wood |
spellingShingle |
Hayet Amalou Bradford J. Wood Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma Case Reports in Urology |
author_facet |
Hayet Amalou Bradford J. Wood |
author_sort |
Hayet Amalou |
title |
Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma |
title_short |
Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma |
title_full |
Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma |
title_fullStr |
Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma |
title_full_unstemmed |
Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma |
title_sort |
multimodality fusion with mri, ct, and ultrasound contrast for ablation of renal cell carcinoma |
publisher |
Hindawi Limited |
series |
Case Reports in Urology |
issn |
2090-696X 2090-6978 |
publishDate |
2012-01-01 |
description |
Fusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure. This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor ablation, in whom there is a desire to minimize or avoid nephrotoxic iodinated contrast exposure. EM tracking software merges and fuses different imaging modalities such as MRI, CT, and ultrasound and can also display the position of needles in real time in relation to preprocedure imaging, which may better define tumor targets than available intraoperative imaging. EM tracking was successfully used to ablate a poorly visualized renal tumor, through the combined use of CT, gadolinium-enhanced MR, and contrast-enhanced US imaging to localize the tumor. |
url |
http://dx.doi.org/10.1155/2012/390912 |
work_keys_str_mv |
AT hayetamalou multimodalityfusionwithmrictandultrasoundcontrastforablationofrenalcellcarcinoma AT bradfordjwood multimodalityfusionwithmrictandultrasoundcontrastforablationofrenalcellcarcinoma |
_version_ |
1725622261144092672 |